CD274 and neoplasm: Furthermore, Gong et al. showed that the upregulation of PD-1 mediates tumor resistance against cytostatic chemotherapy with gemcitabine and oxaliplatin, and therapeutic interventions that target PD-1/PD-L1 interaction might contribute to overcome drug resistance [141].